EASTERN MAINE MEDICAL CENTER
1. Target Overview & Investment Thesis
EASTERN MAINE MEDICAL CENTER is a 352-bed large academic medical center in PENOBSCOT, ME with $2.05B in net patient revenue and a 48.1% operating margin. The hospital serves a payer mix of 24.5% Medicare, 12.9% Medicaid, and 62.6% commercial.
Thesis: Platform Growth. Our ML models identify $150.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 48.1% to 55.5% (+736bps).
| Net Revenue HCRIS | $2.05B |
| Current EBITDA COMPUTED | $986.0M |
| Operating Margin COMPUTED | 48.1% |
| Occupancy HCRIS | 85.9% |
| Revenue / Bed COMPUTED | $5.8M |
| Net-to-Gross HCRIS | 55.9% |
| Distress Probability ML | 39.0% |
2. Market Context & Competitive Position
ME has 38 Medicare-certified hospitals with a median operating margin of -8.3%. The target's margin of 48.1% places it above the state median. Among 1331 size-comparable peers (176-704 beds), the median margin is -3.8%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (176-704), prioritizing same-state peers. 1331 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| EASTERN MAINE MEDICAL CENTER (Target) | ME | 352 | $2.05B | 48.1% |
| ST. LUKES HOSPITAL | PA | 633 | $8.94B | 87.9% |
| STANFORD HEALTH CARE | CA | 657 | $6.76B | 3.7% |
| MEMORIAL HOSPITAL FOR CANCER A | NY | 514 | $4.34B | -32.5% |
| UC DAVIS MEDICAL CENTER | CA | 666 | $3.28B | -11.5% |
| U OF U HOSPITALS & CLINICS | UT | 616 | $2.72B | -1.8% |
| THE CHILDRENS HOSPITAL OF PHIL | PA | 667 | $2.70B | -26.8% |
| UNIVERSITY OF WI HOSPITALS & C | WI | 644 | $2.68B | 3.2% |
| RONALD REAGAN UCLA | CA | 446 | $2.62B | -6.8% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $150.9M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $43.0M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $41.0M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $40.6M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $24.9M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $1.3M | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $986.0M |
| + RCM Uplift | +$150.9M |
| Pro Forma EBITDA | $1.14B |
| Current Margin | 48.1% |
| Pro Forma Margin | 55.5% |
| WC Released (1x) | $78.6M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $1.52B | $8.01B | 5.28x | 39.5% |
| Base (11x exit) | 10.0x | 11.0x | $1.52B | $9.31B | 6.14x | 43.7% |
| Bull Case | 9.0x | 11.0x | $1.37B | $10.30B | 7.54x | 49.8% |
| Bull (12x exit) | 9.0x | 12.0x | $1.37B | $11.64B | 8.52x | 53.5% |
| Bear Case | 11.0x | 10.0x | $1.67B | $6.77B | 4.05x | 32.3% |
| Bear (11x exit) | 11.0x | 11.0x | $1.67B | $7.98B | 4.78x | 36.8% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 1331 hospitals with 176-704 beds
- Same-state prioritization (n=4)
- Comp margins: P25=-13.2% / P50=-3.8% / P75=5.4%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.